Paul Ameloot
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
-
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Cell death mechanisms and regulation 4
- Glycosylation and Glycoproteins Research 2
- RNA Interference and Gene Delivery 2
-
- Immune Response and Inflammation 7
- Co-authors
- Nico Callewaert (7 shared papers)Pieter P. Jacobs (2 shared papers)Kathleen Van Craenenbroeck (1 shared paper)Stefan Ryckaert (1 shared paper)Peter Brouckaert (9 shared papers)Peter Vandenabeele (4 shared papers)Walter Fiers (6 shared papers)D. Coomans (5 shared papers)
- Journals
- Archives of Oral Biology (3 papers)Virology (2 papers)Journal of Biological Chemistry (2 papers)Shock (1 paper)International Immunology (1 paper)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Paul Ameloot
28 papers receiving 478 citations
Peers
Comparison fields: 5 of 83
- Biotechnology 54
- Cell Biology 80
- Immunology 95
- Parasitology 27
- Endocrinology 20
Countries citing papers authored by Paul Ameloot
This map shows the geographic impact of Paul Ameloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ameloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ameloot more than expected).
Fields of papers citing papers by Paul Ameloot
This network shows the impact of papers produced by Paul Ameloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ameloot. The network helps show where Paul Ameloot may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Ameloot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 172 | |
| 2 | 2015 | 40 | |
| 3 | 2001 | 31 | |
| 4 | 2001 | 25 | |
| 5 | 2013 | 25 | |
| 6 | 1998 | 20 | |
| 7 | 2006 | 16 | |
| 8 | 2016 | 16 | |
| 9 | 1987 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 1998 | 13 | |
| 12 | 2006 | 12 | |
| 13 | 2002 | 11 | |
| 14 | 2001 | 10 | |
| 15 | Inhibition of and sensitization to the lethal effects of tumor necrosis factor. | 1997 | 10 |
| 16 | Differential response of a(2)-macroglobulin-deficient mice in models of lethal TNF-induced inflammation. | 2000 | 9 |
| 17 | 2004 | 8 | |
| 18 | 1984 | 8 | |
| 19 | 1986 | 7 | |
| 20 | 1987 | 6 |
About Paul Ameloot
Paul Ameloot is a scholar working on Molecular Biology, Immunology, Epidemiology, Oncology and Rheumatology, having authored 29 papers that have together received 487 indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), Cell death mechanisms and regulation (4 papers), Bone and Dental Protein Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Plant Virus Research Studies (3 papers), Trypanosoma species research and implications (2 papers), Glycosylation and Glycoproteins Research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biotechnology (54 citations), Cell Biology (80 citations), Immunology (95 citations), Parasitology (27 citations) and Endocrinology (20 citations). Paul Ameloot has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Nico Callewaert, Pieter P. Jacobs, Kathleen Van Craenenbroeck, Stefan Ryckaert, Peter Brouckaert, Peter Vandenabeele, Walter Fiers, D. Coomans, John van Emmelo and Walter Fiers. Their work appears in journals such as Archives of Oral Biology, Virology, Journal of Biological Chemistry, Shock and International Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.